Aberrant expression of lncRNA ABHD11‐AS1 has been reported to be involved in regulating the development and progression of various tumors, including endometrial carcinoma, bladder cancer, colorectal cancer, and gastric cancer. Here, ABHD11 is linked to urinary bladder carcinoma.